Furthermore, HDAC inhibitors dramatically sensitised pancreatic cancer cells to IL‐13‐PE cytotoxicity in vitro and in animal models of human pancreatic cancer.59 The gene discussed is HDAC9; the disease is familial pancreatic carcinoma.